Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Genetic toxicity: in vitro

Currently viewing:

Administrative data

Endpoint:
in vitro gene mutation study in bacteria
Remarks:
Type of genotoxicity: gene mutation
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1989
Report date:
1989

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 471 (Bacterial Reverse Mutation Assay)
Deviations:
yes
Remarks:
(only four strains tested; 2-aminoanthracene was the sole indicator of S9 efficancy)
GLP compliance:
no
Type of assay:
bacterial reverse mutation assay

Test material

Constituent 1
Chemical structure
Reference substance name:
Isotridecan-1-ol
EC Number:
248-469-2
EC Name:
Isotridecan-1-ol
Cas Number:
27458-92-0
Molecular formula:
C13H28O
IUPAC Name:
2-methyldodecan-1-ol
Details on test material:
- Name of test material (as cited in study report): Isotridecanol
- Analytical purity: not stated
- Composition of test material, percentage of components: C10H21OH: 0.6%, C11H23OH: 10.2%, C12H25OH: 22.3%, C13H27OH: 62.2%, C14H29OH: 4.7%, C15H31OH: trace
- Physical state: liquid, colorless
- Lot/batch No.: continuous production
- Test substance No: 88/574
- Storage condition of test material: Room temperature

Method

Target gene:
his-gene
Species / strain
Species / strain / cell type:
other: Salmonella typhimurium TA1535, TA100, TA1537, TA98
Metabolic activation:
with and without
Metabolic activation system:
rat liver S-9 mix (rats pretreated with Aroclor 1254)
Test concentrations with justification for top dose:
20 µg - 5000 µg/plate (SPT), 20 µg - 5000 µg/plate (PIT)
Vehicle / solvent:
- Vehicle(s)/solvent(s) used: DMSO
Controls
Untreated negative controls:
no
Negative solvent / vehicle controls:
yes
True negative controls:
no
Positive controls:
yes
Positive control substance:
other: see: Details on test system and conditions
Details on test system and experimental conditions:
METHOD OF APPLICATION: in agar (plate incorporation); preincubation;

Standard plate test
-------------------
The experimental procedure is based on the method of Ames et al. (1973, 1975).
Test tubes containing 2 ml portions of soft agar which consists of 100 ml agar (0.6% agar + 0.6 % NaCl) and 10 ml amino acid solution (minimal amino acid solution for the determination of mutants: 0.5 mM histidine + 0.5 mM biotin) are kept in a water bath at 45°C, and the remaining components are added in the following order:

0.1 ml test solution
0.1 ml bacterial suspension
0.5 ml S-9 mix (in tests with metabolic activation)
or
0.5 ml phosphate buffer (in tests without metabolic activation)

After mixing, the samples are poured onto Vogel-Bonner agar plates (minimal glucose agar plates) within approx. 30 seconds.

Preincubation test
-------------------
The experimental procedure is based on the method described by Yahagi et al. (1977) and Matsushima et al. (1980)

0.1 ml test solution, 0.1 ml bacterial suspension and 0.5 ml S-9 mix are incubated at 37°C for the duration of 20 minutes. Subsequently, 2 ml of soft agar is added and, after mixing, the samples are poured onto the Vogel-Bonner agar plates within approx. 30 seconds.

After incubation at 37°C for 48 hours in the dark, the bacterial colonies (his+ revertants) are counted.

NUMBER OF REPLICATIONS: 3 test plates per dose or per control

Positive controls
-----------------
The following positive control substances are used to check the mutability of the bacteria and the activity of the S-9 mix:

with S-9 mix:
10 µg 2-aminoanthracene (dissolved in DMSO) for the strains TA 100, TA 98, TA 1537 and TA 1535

without S-9 mix:
5 µg N-methyl-N'-nitro-N-nitrosoguanidine (MNNG; dissolved in DMSO) for the strains TA 100 and TA 1535
10 µg 4-nitro-o-phenylendiamine (dissolved in DMSO) for the strain TA 98
100 µg 9-aminoacridine chloride monohydrate (dissolved in DMSO) for the strain TA 1537
Evaluation criteria:
In general, a substance to be characterized as positive in the Ames test has to fulfill the following requirements:

- doubling of the spontaneous mutation rate (control)
- dose-response relationship
- reproducibility of the results

Results and discussion

Test results
Species / strain:
other: Salmonella typhimurium TA1535, TA100, TA1537, TA98
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity
Vehicle controls validity:
valid
Untreated negative controls validity:
not examined
Positive controls validity:
valid
Additional information on results:
TEST-SPECIFIC CONFOUNDING FACTORS
- Precipitation: The test substance was completely soluble in DMSO.


Remarks on result:
other: all strains/cell types tested
Remarks:
Migrated from field 'Test system'.

Any other information on results incl. tables

 1st/2nd experiment, Standard plate test (20 - 5000 µg/plate)
Strain Metabolic activation system mean his+revertant colonies (negative control) maximum revertant factor (conc. (µg/plate)) dose dependency Assessment maximum revertant factor (positive control)
TA 98 no 23 1.2 (2500) no negative 29 (NPD)
  yes 34 1.1 (100/500) no negative 34.7 (2-AA)
TA 100 no 114 1.0 (20/100) no negative 14.8 (MNNG)
  yes 103 1.2 (100) no negative 17.2 (2-AA)
TA 1537 no 9 1.1 (20) no negative 186.7 (AAC)
  yes 10 1.0 (500) no negative 17.6 (2-AA)
TA 1535 no 16 1.4 (500) no negative 87.3 (MNNG)
  yes 18 1.1 (5000) no negative 8.4 (2-AA)
3rd experiment, Preincubation test (20 - 5000 µg/plate)
Strain Metabolic activation system mean his+revertant colonies (negative control) maximum revertant factor (conc. (µg/plate)) dose dependency Assessment maximum revertant factor (positive control)
TA 98 no 24 1.1 (20/100) no negative 39.2 (NPD)
  yes 35 1.1 (100/500) no negative 40.2 (2-AA)
TA 100 no 125 0.9 (100/500) no negative 9.8 (MNNG)
  yes 111 1.1 (20) no negative 16.4 (2-AA)
TA 1537 no 9 1.2 (100) no negative 48.6 (AAC)
  yes 12 1.1 (20) no negative 14.5 (2-AA)
TA 1535 no 18 1.2 (2500) no negative 86.4 (MNNG)
  yes 21 1.0 (2500/5000) no negative 7.8 (2-AA)
2-AA: 2-aminoanthracene
MNNG: N-methyl-N'-nitro-N-nitroso-guanidine
NPD: 4-nitro-o-phenylendiamine
AAC: 9-aminoacridine chloride monohydrate

Applicant's summary and conclusion